1. Cardamonin induces G2/M phase arrest and apoptosis through inhibition of NF-κB and mTOR pathways in ovarian cancer
   Jiang Ruibin et al, 2020, Aging CrossRef
2. Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer Therapy
   Audrey Nathania Johan et al, 2022, Pharmaceuticals CrossRef
3. Anti-Cancer Activity of a 5-Aminopyrazole Derivative Lead Compound (BC-7) and Potential Synergistic Cytotoxicity with Cisplatin against Human Cervical Cancer Cells
   Bresler Swanepoel et al, 2019, International Journal of Molecular Sciences CrossRef
4. Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity
   Jie Zhou et al, 2022, Disease Markers CrossRef
5. An overview of the potential anticancer properties of cardamonin
   Shanaya Ramchandani et al, 2020, Exploration of Targeted Anti-tumor Therapy CrossRef
6. Platinum drugs and taxanes: can we overcome resistance?
   Elena V. Sazonova et al, 2021, Cell Death Discovery CrossRef
7. Possible Participation of Ionotropic Glutamate Receptors and l-Arginine-Nitric Oxide-Cyclic Guanosine Monophosphate-ATP-Sensitive K+ Channel Pathway in the Antinociceptive Activity of Cardamonin in Acute Pain Animal Models
   Chung Pui Ping et al, 2020, Molecules CrossRef